Early research (Phase 1)UnknownNCT03576014
What this trial is testing
Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient
Who this might be right for
Cytomegalovirus InfectionsPreventation of Cytomegalovirus ReactivationBK Virus Infection+1 more
SL VAXiGEN 18